Congenital Adrenal Hyperplasia

  • Anil Bhansali
  • Anuradha Aggarwal
  • Girish Parthan
  • Yashpal Gogate


A 15-day-old child was brought by her parents for repeated vomiting, excessive crying and jitteriness, and poor feeding. She was a product of non-consanguineous marriage and was delivered by induced labor at 33 weeks of gestation due to maternal complications (pregnancy-induced hypertension). Her birth weight was 1.9 kg and she was assigned female gender. She was investigated and found to have hyponatremia and hyperkalemia (Na+ 119 mEq/L, K+ 8.1 mEq/L) and was diagnosed to have hypoaldosteronism. She was initiated with fludrocortisone 50 μg/day. With this treatment, her symptoms subsided but she failed to thrive and progressively became darker; however, serum electrolyte abnormalities were resolved. She was taken to an endocrinologist at 5 months of age, and she was suspected to have congenital adrenal hyperplasia (CAH) and was investigated accordingly. Her unstimulated serum 17α-hydroxyprogesterone [17(OH)P] was 120 ng/ml and was diagnosed to have CAH due to 21α-hydroxylase deficiency, and dexamethasone was added to fludrocortisone. This therapy resulted in weight gain and decrease in pigmentation, and patient became more active. At 2 years of age, she was referred to our institute. Her height was 81 cm (10th percentile, target height 158 cm), weight 12 kg (25th percentile), and she had a Tanner staging of A-, P1, B1. She did not have Cushing’s stigmata. Examination of the external genitalia showed posterior labial fusion, hyperpigmented labioscrotal folds, isolated clitoromegaly, and the gonads were not palpable. Two distinct openings were seen at perineum. The karyotype was 46,XX. Serum 17(OH)P was 26.8 ng/ml. Dexamethasone was replaced with hydrocortisone (7.5 mg/day) and fludrocortisone (100 μg/day) was continued. The annual follow-up of the patient with clinical and biochemical parameters is depicted in the table given below.


Congenital Adrenal Hyperplasia GnRH Agonist Urogenital Sinus Classical Congenital Adrenal Hyperplasia Genital Ambiguity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Further Readings

  1. 1.
    DeGroot L, Jameson J. Endocrinology. Philadelphia: Saunders/Elsevier; 2010.Google Scholar
  2. 2.
    Han TS, Walker BR, Arlt W, Ross RJ. Treatment and health outcomes in adults with congenital adrenal hyperplasia. Nat Rev Endocrinol. 2014;10:115–24.CrossRefPubMedGoogle Scholar
  3. 3.
    Kaye CI, Committee on Genetics, Accurso F, et al. Newborn screening fact sheets. Pediatrics. 2006;118:e934.CrossRefPubMedGoogle Scholar
  4. 4.
    Krone N, Arlt W. Genetics of congenital adrenal hyperplasia. Baillieres Best Pract Res Clin Endocrinol Metab. 2009;23:181–92.CrossRefGoogle Scholar
  5. 5.
    Melmed S, Williams R. Williams textbook of endocrinology. Philadelphia: Elsevier/Saunders; 2011.Google Scholar
  6. 6.
    Mercè Fernández-Balsells M, Muthusamy K, Smushkin G, et al. Prenatal dexamethasone use for the prevention of virilization in pregnancies at risk for classical congenital adrenal hyperplasia because of 21-hydroxylase (CYP21A2) deficiency: a systematic review and meta-analyses. Clin Endocrinol (Oxf). 2010;73:436–44.Google Scholar
  7. 7.
    Merke DP, Bornstein SR. Congenital adrenal hyperplasia. Lancet. 2005;365:2125–36.CrossRefPubMedGoogle Scholar
  8. 8.
    Merke DP, Keil MF, Jones JV, Fields J, Hill S, Cutler Jr GB. Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2000;85:1114–20.CrossRefPubMedGoogle Scholar
  9. 9.
    Nimkarn S, Lin-Su K, New M. Steroid 21-hydroxylase deficiency congenital adrenal hyperplasia. Pediatr Clin North Am. 2011;58:1281–300.CrossRefPubMedGoogle Scholar
  10. 10.
    Speiser P, Azziz R, Baskin L, Ghizzoni L, Hensle T, Merke D, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2010;95:4133–60.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer India 2016

Authors and Affiliations

  • Anil Bhansali
    • 1
  • Anuradha Aggarwal
    • 2
  • Girish Parthan
    • 3
  • Yashpal Gogate
    • 4
  1. 1.Department of EndocrinologyPostgraduate Institute of Medical Education and ResearchChandigarhIndia
  2. 2.Paras HospitalPatnaIndia
  3. 3.Renal MedicityCochinIndia
  4. 4.Harmony Health HubNasikIndia

Personalised recommendations